Drug product
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
D-0508-2026
Product summary
- Event
- Event 98694
- Status
- Ongoing
- Classification
- Class II
- Quantity
- 50 syringes
- Official record key
drug-enforcement:D-0508-2026
Official wording
Reason: cGMP deviations.
Code information: Lot 020226202150202, Exp Date 05/05/2026.
Distribution pattern: U.S. Nationwide.
Derived failure modes
-
Manufacturing or process control
cGMP deviations